statementSaid on 2026-11-03
국민성장펀드가 GC녹십자의 '차세대 혈액제제'에 1700억원 저리대출을 승인했다.
A statement by post author, said on 2026-11-03. Statements are as reported by the cited publishers — not verified by DecisionGateway.
국민성장펀드, GC녹십자 '차세대 혈액제제' 1700억 저리대출 승인
A statement by post author, said on 2026-11-03. Statements are as reported by the cited publishers — not verified by DecisionGateway.
국민성장펀드, GC녹십자 '차세대 혈액제제' 1700억 저리대출 승인